Your browser doesn't support javascript.
loading
Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach.
Katona, Gábor; Balogh, György Tibor; Dargó, Gergo; Gáspár, Róbert; Márki, Árpád; Ducza, Eszter; Sztojkov-Ivanov, Anita; Tömösi, Ferenc; Kecskeméti, Gábor; Janáky, Tamás; Kiss, Tamás; Ambrus, Rita; Pallagi, Edina; Szabó-Révész, Piroska; Csóka, Ildikó.
  • Katona G; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged H-6720, Hungary.
  • Balogh GT; Department of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Budapest H-1111, Hungary.
  • Dargó G; Faculty of Pharmacy, Department of Pharmacodynamics and Biopharmacy, University of Szeged, Szeged H-6720, Hungary.
  • Gáspár R; Department of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Budapest H-1111, Hungary.
  • Márki Á; Faculty of Medicine, Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged H-6720, Hungary.
  • Ducza E; Faculty of Medicine, Department of Medical Physics and Informatics, University of Szeged, Szeged H-6720, Hungary.
  • Sztojkov-Ivanov A; Faculty of Pharmacy, Department of Pharmacodynamics and Biopharmacy, University of Szeged, Szeged H-6720, Hungary.
  • Tömösi F; Faculty of Pharmacy, Department of Pharmacodynamics and Biopharmacy, University of Szeged, Szeged H-6720, Hungary.
  • Kecskeméti G; Interdisciplinary Excellence Centre, Department of Medical Chemistry, University of Szeged, Szeged H-6720, Hungary.
  • Janáky T; Interdisciplinary Excellence Centre, Department of Medical Chemistry, University of Szeged, Szeged H-6720, Hungary.
  • Kiss T; Interdisciplinary Excellence Centre, Department of Medical Chemistry, University of Szeged, Szeged H-6720, Hungary.
  • Ambrus R; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged H-6720, Hungary.
  • Pallagi E; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged H-6720, Hungary.
  • Szabó-Révész P; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged H-6720, Hungary.
  • Csóka I; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged H-6720, Hungary.
Pharmaceutics ; 12(2)2020 Jan 25.
Article en En | MEDLINE | ID: mdl-31991767